Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03461965
Other study ID # CASE6617
Secondary ID T32AR007569
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2018
Est. completion date January 25, 2019

Study information

Verified date April 2021
Source Case Comprehensive Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients undergoing Mohs micrographic surgery (MMS) frequently experience anxiety. It has been suggested that enhanced patient education prior to the procedure may decrease patient anxiety. The purpose of the study is to investigate if optimized participant education enhances participant understanding, decreases participant anxiety and increases participant satisfaction.


Description:

1. To investigate if participant education with a 3 dimensional printed (3DP) MMS model and standardized script protocol increases participant understanding of MMS more than current standard of care (control group) at the University Hospitals Cleveland Medical Center MMS Clinics. 2. To investigate if participant education with a 3DP MMS model and standardized script protocol decreases perioperative participant anxiety during MMS more than current standard of care (control group) at the University Hospitals Cleveland Medical Center MMS Clinics. 3. To evaluate if participant satisfaction with a 3DP MMS model and standardized script protocol increases participant satisfaction during MMS more than current standard of care (control group) at the University Hospitals Cleveland Medical Center MMS Clinics.


Recruitment information / eligibility

Status Completed
Enrollment 82
Est. completion date January 25, 2019
Est. primary completion date January 25, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Patients undergoing MMS at University Hospitals Cleveland Medical Center, Chagrin Highlands and Westlake Campus - Capable of reading and completing all subjective questionnaires Exclusion Criteria: - Cannot complete the survey measures independently for any reason

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
3D printed model
A printed 3D model of MMS will be created showing a model of skin, and a tumor to visually depict the surgery
Verbal Counselling
Participants will be educated with a standardized script on skin cancer, risks for skin cancer, treatment options, and MMS

Locations

Country Name City State
United States University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland Ohio

Sponsors (2)

Lead Sponsor Collaborator
Case Comprehensive Cancer Center National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percent of Correct and Incorrect Mohs Quiz Responses This is an in-house-designed, short questionnaire with 6 multiple choice objective questions related to the participant's understanding of Mohs. A higher percentage of correct answers indicate a better understanding of Mohs.
Reported data are percent of responses answered correctly and incorrectly totaled across all participants in each arm
Post surgery (1 day)
Secondary Change in State-Trait Anxiety Inventory (STAI) Y-1 (State Anxiety) Score The STAI is a well-known, frequently used measure of patient anxiety within the clinical setting. This form consists of two forms to assess state anxiety (Y-1) and a participant's baseline trait anxiety (Y-2).
The Y-1 form consists of 20 Likert-type questions with scores ranging from 20 to 80, with higher scores indicating higher anxiety. Reported values are change in "state anxiety' (post-stage minus baseline)
From baseline to post surgery (1 day)
Secondary Change in Visual Analog Scale (VAS) Anxiety Score The VAS is a frequently employed Likert-type scale that is used to measure anxiety. This 0-10 scale documents the patients current state of anxiety, with higher scores indicating worse anxietey, and can be answered by patients with an average reading level. Estimated time of completion is under 30 seconds. This form has been used in 2 studies to date and previously by experimental team to assess intraoperative anxiety in Mohs. From baseline to post surgery (1 day)
Secondary Change in Visual Analog Scale (VAS) Understanding Score The VAS is a frequently employed Likert-type scale that because of the ease of use this tool has been converted to assess other objective measures including understanding. This 0-10 scale documents the participant's current state of understanding, with higher scores indicating better understanding, and can be answered by patients with an average reading level. Estimated time of completion is under 30 seconds. This form has been used by experimental team to assess intraoperative understanding in Mohs. From baseline to post surgery (1 day)
Secondary Satisfaction Survey Score Participants were provided 3 subjective questions related to their satisfaction with the explanation of MMS that they received. This scale included questions regarding satisfaction with their explanation of the MMS procedure, if the explanation used could be improved, and if they recommended other patients be provided a similar explanation of MMS, with each question scored from 1 to 5, with higher scores indicating greater satisfaction. Total score range is 0 to 15, with higher scores indicating greater satisfaction. Post surgery (1 day)
See also
  Status Clinical Trial Phase
Completed NCT04015453 - Correlation of Early Postoperative Scar Appearance With Long-term Scar Outcomes
Withdrawn NCT04117373 - Mohs Micrographic Surgery and Reconstruction in the Optum Insurance Claims Database
Completed NCT04164550 - Interpolated Flap Study